HUT62787A - Process for producing antitumoral pharmaceutical composition comprising a reduced toxicity cytostatic agent and a xanthogenate - Google Patents

Process for producing antitumoral pharmaceutical composition comprising a reduced toxicity cytostatic agent and a xanthogenate

Info

Publication number
HUT62787A
HUT62787A HU92115A HU11592A HUT62787A HU T62787 A HUT62787 A HU T62787A HU 92115 A HU92115 A HU 92115A HU 11592 A HU11592 A HU 11592A HU T62787 A HUT62787 A HU T62787A
Authority
HU
Hungary
Prior art keywords
xanthogenate
producing
pharmaceutical composition
reduced toxicity
cytostatic agent
Prior art date
Application number
HU92115A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9200115D0 (en
Inventor
Gerhard Sauer
Eberhard Amtmann
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Publication of HU9200115D0 publication Critical patent/HU9200115D0/hu
Publication of HUT62787A publication Critical patent/HUT62787A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU92115A 1990-05-15 1991-05-14 Process for producing antitumoral pharmaceutical composition comprising a reduced toxicity cytostatic agent and a xanthogenate HUT62787A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4015603 1990-05-15
DE4115559A DE4115559A1 (de) 1990-05-15 1991-05-13 Antitumormittel mit verminderter toxizitaet auf der basis von cytostatika und xanthogenaten

Publications (2)

Publication Number Publication Date
HU9200115D0 HU9200115D0 (en) 1992-06-29
HUT62787A true HUT62787A (en) 1993-06-28

Family

ID=25893234

Family Applications (1)

Application Number Title Priority Date Filing Date
HU92115A HUT62787A (en) 1990-05-15 1991-05-14 Process for producing antitumoral pharmaceutical composition comprising a reduced toxicity cytostatic agent and a xanthogenate

Country Status (8)

Country Link
EP (1) EP0482172A1 (de)
JP (1) JPH05500067A (de)
AU (1) AU7870791A (de)
CA (1) CA2064067A1 (de)
DE (1) DE4115559A1 (de)
HU (1) HUT62787A (de)
IE (1) IE911650A1 (de)
WO (1) WO1991017757A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4415263C1 (de) * 1994-04-15 1995-11-30 Asta Medica Ag Cis-[trans-1,2-Cyclobutanbis(methylamin)-N,N']-[(2S)-lactato-O·1·, O·2·]-platin(II)-trihydrat (Lobaplatin-Trihydrat), seine Herstellung und arzneiliche Verwendung
EP1391221A1 (de) * 2002-08-23 2004-02-25 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Pharmazeutische Zubereitung enthaltend Palladiumkomplexverbindungen und deren Verwendung zur Behandlung von Krebs und Autoimmunerkrankungen
DE10343365A1 (de) * 2003-09-17 2005-04-14 Biosphings Ag Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3625948A1 (de) * 1985-08-02 1987-02-19 Merz & Co Gmbh & Co Antivirale und antitumor-zusammensetzung, verfahren zu deren herstellung und deren verwendung

Also Published As

Publication number Publication date
EP0482172A1 (de) 1992-04-29
WO1991017757A1 (en) 1991-11-28
IE911650A1 (en) 1991-11-20
DE4115559A1 (de) 1991-11-21
JPH05500067A (ja) 1993-01-14
CA2064067A1 (en) 1991-11-16
HU9200115D0 (en) 1992-06-29
AU7870791A (en) 1991-12-10

Similar Documents

Publication Publication Date Title
HUT60784A (en) Process for producing n,o-sulfated heparosanes and pharmaceutical compositions comprising such compounds
HUT63628A (en) Process for producing new cefalosporing derivatives and pharmaceutical compositions comprising same
HUT62559A (en) Process for producing 1 alpha-hydroxy-d4-vitamins and pharmaceutical compositions comprising same
HUT63859A (en) Process for producing cyclopeptides and pharmaceutical compositions comprising same
HUT57202A (en) Process for producing new pharmaceutically active 5-fluoro-2-///4-/cyclopropyl-methoxy/-2-pyridinyl/-methyl-sulfonyl/-1h-benzimidazol and pharmaceutical compositions containing them
HUT58745A (en) Process for produicng rapamycin derivatives and pharmaceutical compositions containing them as active components
HUT56270A (en) Process for producing taxol derivatives and pharmaceutical compositions comprising such active ingredient
HUT59088A (en) Process for producing acetamide derivatives and pharmaceutical compositions containing them as active components
HUT54112A (en) Process for producing benzocycloalkane derivatives and pharmaceutical compositions comprising same
EP0470617A3 (en) 17-substituted corticoid-17-alkylcarbonates, a process for their preparation and pharmaceutical compositions containing them
HUT61731A (en) Process for producing glycinamide derivatives and pharmaceutical compositions comprising same
HUT54671A (en) Process for producing benzothiopirane derivatives and pharmaceutical compositions containing them as active component
HUT49871A (en) Process for producing indolylpiperidine derivatives and pharmaceutical compositions comprising same
HUT53625A (en) Process for producing 2-iminobenzothiazole derivatives and pharmaceutical compositions comprising same
HUT58736A (en) Process for producing new purine derivatives and pharmaceutical compositions containing them as active components
HUT50829A (en) Process for producing thienoazepines and pharmaceutical compositions comprising same
EP0558961A3 (en) Glycopeptide derivatives, process for their manufacture and pharmaceutical compositions comprising them
ZA918273B (en) A new 5H-benzodiazepine derivative pharmaceutical compositions containing same and process for preparing them
IL97656A0 (en) Purine derivatives,process for their preparation and pharmaceutical compositions comprising them
HUT62787A (en) Process for producing antitumoral pharmaceutical composition comprising a reduced toxicity cytostatic agent and a xanthogenate
HUT52163A (en) Process for producing antibiotic bu-3420t and pharmaceutical compositions comprising such antibiotic
HUT53620A (en) Process for producing new thiouracyl derivatives and pharmaceutical compositions comprising same
HUT58081A (en) Process for producing aminodiol derivatives and pharmaceutical compositions comprising same
HUT54165A (en) Process for producing cefalosporin derivatives and pharmaceutical compositions comprising same
HUT60711A (en) Process for producing new crystalline (s)-norfluoxetine and pharmaceutical composition comprising the active ingredient